resident diagnosed with a type of inflammatory myopathy or be going through a diagnostic process in which doctors strongly suspect and are testing the patient for one of the forms of myositis through muscle or skin biopsy, EMG, and/or blood work. citizen or permanent resident, Prescribed an FDA-approved treatment, Meet Financial eligibility criteria based, and upon household income and size Ĭovered Drugs: A-Hydrocort, A-Methapred, Acthar, Beta 1 Kit, Bethamethasone Acetate Pow, Bethamethasone Sodium Phosphate, Cortef, Cortisone Acetate, Depo-Medrol, Dexamethasone, Dexpak, Hydrocortisone, Kenalog-40, Medrol, Methylprednisolone, Millipede, Octagam, Prednisone, Pro-C Dure, Purified Cortrophin Gel, Rayos, Solu-Cortef, and Solu-Medrol. Sanofi – Sanofi Patient Access Connection – The Assistance FundsĮligibility Criteria: U.S.The Safety Net Foundation – provides Enbrel for free funded through Amgen –.Mallinckrodt Pharmaceuticals – Patient Assistance Program.Johnson & Johnson – Johnson and Johnson Patient Assistance Foundation.Horizon Pharma – Patient Assistance Program.Genentech – Genentech Rheumatology Access Solutions.Bristol-Meyers Squibb – BMS Access Support.AbbVie – Patient Assistance Foundation.Xeljanz (tofacitinib citrate) up to $8,000 per year- Pharmaceutical Assistance.Rituxan (rituximab) $5 copay up to $25,000 per year (FDA-approved indications only).Rasuvo (methotrexate) $125 in copay assistance.Prograf (tacrolimus) $0 copay up to $3,000.Plaquenil (hydroxychloroquine) $0 copay.Orencia (abatacept) $5 per month up to $10,000 per year.Inflectra (infliximab-dyyb) up to $20,000.Entyvio (vedolizumab) pay as little as $5 per does up to $20,000 per year.Enbrel (etanercept) $0 out-of-pocket for first 6 months $10 or less each month after 6 months.Sotyktu Patient Support Program: This program offers co-pay assistance and other resources to eligible patients. More information is expected to be available soon on the official Sotyktu® website. Deucravacitinib Bristol Myers Squibb Patient Assistance Foundation (BMSPAF): This program from Bristol Myers Squibb, the manufacturer of Sotyktu®, can help eligible patients with their co-pays. You can check eligibility and enroll online or by calling 1-80.CellCept (mycophenolate mofetil)- will say up to $330 per prescription/refill after patient has paid the first $20.Also visit the Lilly Cares Foundation: This non-profit organization provides free medications to eligible patients who meet certain income requirements. You can learn more and see if you qualify on their website. Savings & Support | HCP | Olumiant® (baricitinib) (). baricitinib (Olumiant) please visit the Olumiant Together Patient Assistance Program: This program from Eli Lilly, the manufacturer of Olumiant, can help eligible commercially insured patients with their co-pays. You can check eligibility and enroll online or by calling 1-844-OLUMIANT (1-84).Avsola (infliximab-axxq) $0 out of pocket.Pfizer has assistance program for Octagam and Panzyga up to $12,500.

Octapharma has assistance program for brands Octagam – $2,500, Panzyga – $12,500 and Cutaquig $12,500.

Consider seeking funding assistance through third parties and government sources to make therapies more affordable.

Look into medical assistance programs at infusion centers and physician offices, even if they are not widely advertised.

Explore copay assistance programs, pharmaceutical assistance programs, and patient assistance foundations to help manage the financial burden of expensive medications.

Maintain patience and persistence when dealing with insurance companies due to the complexities of authorization for coverage, and keep a detailed journal of interactions while requesting a call ID number for future reference.

Collaborate closely with the patient’s doctor when navigating the insurance approval and appeal process to find the best course of action.

Request a case manager from the insurance company to streamline the care process and address access issues.

Laurel Cherwin recommended families should:

The experts Laurel Cherwin, BSN, RN, IgCN, and Senior Clinical Nurse Educator at Octapharma and Michelle Vogel, Vice President of Patient Advocacy at IV Solutions RX, MPA had some great tips for our Cure JM Families. No matter where you are in your family’s JM journey or what your individual situation may be, we hope you find these tips and assistance programs helpful in navigating your treatment options. We are excited to share some pro tips that we became aware of from a September presentation to Cure JM grandparents from a couple of Pharmaceutical Industry experts. As JM families, we understand how daunting a task navigating treatments can be, from dealing with insurance roadblocks to navigating the healthcare system and everything in between.

Orencia copay card program